Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

PCI With Intravascular Imaging or Functional Testing Bests Angiography Alone

Michael O'Riordan

November 24, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Daily News

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Michael O'Riordan

July 28, 2023

News Daily News

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Michael O'Riordan

July 18, 2023

News Daily News

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Michael O'Riordan

January 25, 2022

News Daily News

FFR Can Safely Guide PCI Deferral, With Solid Long-term Results: J-CONFIRM

Caitlin E. Cox

January 03, 2020

News Features

Top News in Imaging: 2018

Caitlin E. Cox

December 28, 2018

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

News Conference News EuroPCR 2018

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Michael O'Riordan

May 23, 2018

News Conference News EAS 2017

Plaque Attack: Options Evolve for Imaging Coronaries and Carotids, but Link With Hard Outcomes Remains Elusive

Yael L. Maxwell

May 01, 2017

News Daily News

No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis

Shelley Wood

March 06, 2017

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Daily News

CTA Can Help Identify True CTOs

August 18, 2015

News Daily News

ILUMIEN I Published: OCT Can Affect PCI Strategy

L.A. McKeown

August 17, 2015

News Industry News

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

July 28, 2015

News Daily News

FAME Published: FFR Guidance Improves Outcomes in Multivessel Disease

Kim Dalton

January 14, 2009

Advertisement

PCI With Intravascular Imaging or Functional Testing Bests Angiography Alone

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

FFR Can Safely Guide PCI Deferral, With Solid Long-term Results: J-CONFIRM

Top News in Imaging: 2018

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Plaque Attack: Options Evolve for Imaging Coronaries and Carotids, but Link With Hard Outcomes Remains Elusive

No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

CTA Can Help Identify True CTOs

ILUMIEN I Published: OCT Can Affect PCI Strategy

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

FAME Published: FFR Guidance Improves Outcomes in Multivessel Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content